Sanofi Pasteur, A Sanofi Company

This study tested a new vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV). Researchers wanted to see if giving this RSV vaccine at the same time as a child's regular 6-month and 12-month shots would make the RSV vaccine less effective. The st…

This early-stage study tested a new mRNA vaccine designed to protect against COVID-19. It involved 182 healthy adults and aimed to check the vaccine's safety and measure the body's immune response over one year. The study was terminated early, and its main goal was to gather init…

This study aimed to see if a high-dose flu vaccine works better than the standard-dose vaccine at preventing the flu in very young children, aged 6 months to 3 years. It compared how many children in each group got lab-confirmed influenza and measured the body's immune response t…

This large study tested a new nasal spray vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV), a common cause of serious lung infections. About 6,300 healthy children, aged 6 months to under 2 years, received either the vaccine or a placebo spr…

This early-stage study aimed to test the safety and immune response of a new investigational vaccine designed to protect against Meningitis B, a serious bacterial infection. It involved 576 healthy volunteers, including infants, toddlers, adolescents, and adults, comparing the ne…

This study tested a new nasal spray vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV), a common cause of severe lung infections in young children. It involved about 950 healthy children aged 6 months to under 2 years old. The main goals were …

This study aimed to see if a new type of flu vaccine, made without using eggs, worked as well as the standard egg-based flu shot in children aged 3 to 8 years. Researchers compared the immune response and safety of the two vaccines. The study was terminated early and involved 366…

This study aimed to see if a high-dose flu vaccine works better than a standard-dose vaccine at preventing serious health problems in adults aged 65 and older. Over 33,000 participants received one of the two vaccines. Researchers then tracked hospitalizations and other health ev…